YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. - Wikidata - awgldk - TriplyDB

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

http://www.wikidata.org/entity/Q34349271

about

Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease.A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.TAZ expression as a prognostic indicator in colorectal cancer.TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation.PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.Splice variant insertions in the C-terminus impairs YAP's transactivation domain.Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy.The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression.Hippo pathway deregulation: implications in the pathogenesis of haematological malignancies.Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.YAP and the Hippo pathway in pediatric cancer.VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer Dual roles of yes-associated protein (YAP) in colorectal cancer.YAP1 oncogene and its eight isoforms.Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma.YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.p53 shades of Hippo.Nerve Growth Factor Is Associated With Sexual Pain in Women With Endometriosis.Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets.Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.

P2860

Q28241192-755A4614-E400-4376-A35E-B6AD47F15375 Q30429628-D6B8C2F7-BFD6-40F2-882B-E56C54B520D6 Q30843628-7C88987D-FFF2-4DC6-9391-92B64AD86ECF Q34077954-793C09A6-4697-4276-937C-FD28177D0782 Q34548405-68670170-BF79-4739-98D3-234AD4090775 Q34571020-E9067AE0-E282-4807-BA3F-BDE57D67214D Q35501271-ACC3AEC9-CA09-4231-9EDD-873D57661E76 Q35581149-27BE7BA5-0266-4A00-9C28-8FE356CD892C Q35752244-ACEE93AC-0C67-4DFF-9E08-C5DDCEE38FB6 Q36016084-24F2C90C-34EC-42B8-A37B-B03B508209EA Q36414976-960E8D2C-52EC-44E1-87A8-89E5334BB15D Q36962657-44CA8C4E-55B1-4562-B221-31420F34F80F Q37025086-7BC136DA-EA42-458B-912A-F6CA5513E3DA Q37269206-032B104A-32B5-4FB8-9EF3-331106B49D9E Q37524477-33F1831F-46DE-45A6-AEDD-05555B0EFE64 Q37580201-658D5E13-9167-4342-B1D6-8036703A32FF Q38171966-01AE7817-B9D4-4FA6-BB13-0AB4BE2E21F2 Q38255378-F6388CCB-A371-46E0-AA8F-0BB54EB52010 Q38966843-AF85BB06-7D14-4E69-AA20-114B9D6C39D0 Q38995148-14BB3DA2-7478-40A8-B153-9043D53F52B1 Q39006076-9528641D-E664-4C9A-9754-37AA2A62EFCD Q39374990-E9E6743C-90F3-4A84-AD94-581DC946344D Q41094610-56762315-36D6-42D7-847A-FFCF44E5C936 Q43651454-F05A92DC-E9A3-4ED0-B6F1-EEB2D187B5CA Q45979430-816BD55C-11D1-4FCD-97CD-37F0BCF8CD25 Q47095212-B3B9C453-F171-489A-B6C2-B82B1EA446DA Q47153328-F08F57B4-2761-43F0-B86D-4F886C54844B Q47850800-57810757-10D3-495F-855A-EED7F7D9B3A1 Q50548074-51401B1F-6F0B-49DF-B5F4-9DF9C384C78D Q52607328-BDD98BCA-2D7A-474E-8C37-0CD5B8DE0BE6 Q52658016-E4BF3EA6-438E-4895-A8C9-B32C90295A0D Q54458754-90727880-EC67-4275-B5F9-A399B4A93785 Q55171954-1783F4CF-B071-43EF-A347-575515335152

P2860

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

http://www.wikidata.org/entity/Q34349271

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@ast

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@en

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@nl

type

label

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@ast

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@en

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@nl

prefLabel

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@ast

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@en

YAP dysregulation by phosphory ...... head and neck cancer subsets.

@nl

P1433

Q34349271-F54A3693-D6CD-43F1-A5FC-1B6D881733A2

P1476

Q34349271-A02EC45A-C802-43B1-A4FF-A868AD8096A6

P2093

Q34349271-1542A869-A476-4C6A-8D13-805BD6291506

Q34349271-25072946-C043-4DA8-80A1-11898B038AC2

Q34349271-2A2E46E5-476B-46A5-97E2-20ECE0E9E422

Q34349271-39EA7D98-462B-44F3-B29D-C4674E405469

Q34349271-515131CD-EB57-4B22-96DA-AC30FC20DFA3

Q34349271-5ABF8A0F-DACD-46C9-9048-B8605EB1EEE8

Q34349271-655EA8A4-B19D-4CAA-95C1-703DC57DC664

Q34349271-810283CF-55B7-4603-8E3D-B889B3D9A2E0

Q34349271-86D141ED-BC7B-416D-B2CF-1E6BF2955807

Q34349271-C2D34A5D-99C5-4C4A-ACEA-608B58BEFA13

P2860

Q34349271-078086F9-2BA5-4771-A269-1648738551C0

Q34349271-084D6078-830A-49A3-8BBA-F7A7F37B1FAF

Q34349271-1E8E1004-02A8-45A5-91D9-AD8F7E614E3B

Q34349271-1EE17B38-F6D4-463D-B9CF-6C58E64E4FC7

Q34349271-214DC454-FD0D-4E70-A91B-B0EC01DFF651

Q34349271-2C60E144-73C8-4A42-A2A1-2B93A7A9E0AD

Q34349271-360B726B-A705-4D22-A1CE-B7F123796EB2

Q34349271-4081B93A-E391-4952-8912-D85402886EBB

Q34349271-40E8EBAD-F301-4B58-B59B-61739DD41ECA

Q34349271-445F9F75-C1B3-4AE6-BCEB-2D2911CE00DA

P2888

Q34349271-B7EE4673-FF23-4297-9D06-EB0AF30D607F

P304

Q34349271-940BAF23-C686-453D-A6D5-D534617C47FA

P31

Q34349271-B6A2B48F-47EA-4EB2-80D4-AE530EA1D97C

P356

Q34349271-308E87D2-733C-43C4-972F-75FCD2F3D1F9

P407

Q34349271-78FEED79-CD86-475F-A291-8B6D9DB43E5E

P433

Q34349271-1CAB412C-2AC6-46A0-98C9-BA44BE0B0DC5

P478

Q34349271-96D94154-1383-45FE-8D99-858B87FD5A97

P50

Q34349271-74DAC5A2-296F-4D48-AE20-A06E59BEC985

P577

Q34349271-5CDB90D9-7BA4-427F-9AC9-98C8ECCF3D1F

P5875

Q34349271-D343B9BA-C2A6-4F6B-AB60-5D0A99DD459C

P6179

Q34349271-02D659F8-5E6C-4215-8AB8-FD2C14D8DECA

P698

Q34349271-799BDA85-ACC0-43C1-A62C-A94FD4F92D6A

P921

Q34349271-AA4D3BDD-B81B-4402-885E-72C946B2F32E

P932

Q34349271-88117F2F-35F7-4664-A61C-46B362D49F7A

P356

P1433

P1476

YAP dysregulation by phosphory ...... n head and neck cancer subsets

@en

P2093

A Pattatheyil

http://www.w3.org/2001/XMLSchema#string

B Yan

http://www.w3.org/2001/XMLSchema#string

C Van Waes

http://www.w3.org/2001/XMLSchema#string

H Lu

http://www.w3.org/2001/XMLSchema#string

J Doondeea

http://www.w3.org/2001/XMLSchema#string

M Sudol

http://www.w3.org/2001/XMLSchema#string

P Duggal

http://www.w3.org/2001/XMLSchema#string

R Chuang

http://www.w3.org/2001/XMLSchema#string

R Ehsanian

http://www.w3.org/2001/XMLSchema#string

S Feller

http://www.w3.org/2001/XMLSchema#string

P2860

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage

The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein

Expression of Yes-associated protein in common solid tumors

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus

P2888

P304

6160-6171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2010.339

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45800334

http://www.w3.org/2001/XMLSchema#string

P6179

1031455439

http://www.w3.org/2001/XMLSchema#string

P698

20729916

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

2991596

http://www.w3.org/2001/XMLSchema#string